$128.77
1.38[1.08%]
At close: Apr 26
$128.77
0[0.00%]
After Hours: 4:00PM EDT
Sarepta Therapeutics
(NASDAQ:SRPT)Sarepta Therapeutics Stock (NASDAQ:SRPT), Insider Trading Activity
Sarepta Therapeutics: Insider buying and selling updated today.
Shares Outstanding
94.506M%
Filing Date | Insider Names | Insider Title | Qty. | Price | Size ($) | Type | Δ Own | Own | Trade Dates | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 11, 2024 | Hans Wigzell | 0 | $68.58 | -$1.64M | SELL-OPTIONS | 0.00% | 22.84K | Mar 08 | View | |
| Mar 11, 2024 | Kathryn Boor | -761 | $122.93 | -$93.55K | SELL | -9.19% | 7.516K | Mar 11 | View | |
| Mar 06, 2024 | Stephen Mayo | -3.135K | $122.96 | -$385.48K | SELL | -32.13% | 6.621K | Mar 05 | View | |
| Mar 05, 2024 | Bilal Arif | CHIEF TECH OPS OFFICER | 3.635K | $128.43 | -$303.74K | GRANT | 15.74% | 26.722K | Mar 01 | View |
| Mar 05, 2024 | Ian Estepan | CHIEF FINANCIAL OFFICER | 4.435K | $127.81 | -$200.02K | GRANT | 12.79% | 39.114K | Mar 01 | View |
| Mar 05, 2024 | Ryan Brown | EVP, GENERAL COUNSEL | 3.731K | $125.44 | -$284.63K | GRANT | 13.28% | 31.827K | Mar 01 | View |
| Nov 06, 2023 | Richard Barry | DIRECTOR | 50K | $78.81 | $3.94M | BUY | 1.66% | 3.069842M | Nov 03 | View |
| Nov 06, 2023 | Douglas S Ingram | PRESIDENT & CEO | 25.225K | $79.36 | $2.00M | BUY | 6.91% | 390.307K | Nov 03 | View |
| Aug 15, 2023 | Michael Chambers | DIRECTOR | 9.979K | $109.47 | $1.09M | BUY | 4.10% | 253.427K | Aug 14 | View |
| Aug 14, 2023 | Michael Chambers | DIRECTOR | 23.686K | $108.05 | $2.56M | BUY | 10.78% | 243.448K | Aug 11 | View |
| Aug 11, 2023 | Michael Chambers | DIRECTOR | 34.867K | $106.15 | $3.70M | BUY | 18.86% | 219.762K | Aug 10 | View |
| Aug 08, 2023 | Hans Wigzell | DIRECTOR | 0 | $67.88 | -$1.17M | SELL-OPTIONS | 0.00% | 20.994K | Aug 04 | View |
| Nov 21, 2022 | Stephen Mayo | DIRECTOR | -858 | $109.92 | -$94.31K | SELL | -11.84% | 6.387K | Nov 17 | View |
| Sep 15, 2022 | Michael Andrew Chambers | DIRECTOR | 57.1K | $104.43 | $5.96M | BUY | 45.22% | 183.372K | Sep 14 | View |
| Aug 22, 2022 | Michael Andrew Chambers | DIRECTOR | 46.17K | $108.28 | $5.00M | BUY | 57.64% | 126.272K | Aug 19 | View |
| Nov 29, 2021 | Louise Rodino-Klapac | HEAD R&D, CSO | 3.78K | $79.33 | $299.87K | BUY | 6.11% | 65.678K | Nov 24 | View |
| Nov 17, 2021 | Douglas S Ingram | PRESIDENT & CEO | 25.026K | $79.94 | $2.00M | BUY | 7.36% | 365.082K | Nov 17 | View |
| Mar 10, 2021 | Kathleen Behrens | DIRECTOR | 0 | $64.03 | -$217.30K | SELL-OPTIONS | 0.00% | 140.517K | Mar 10 | View |
| Mar 10, 2021 | Hans Wigzell | DIRECTOR | 0 | $59.22 | -$485.90K | SELL-OPTIONS | 0.00% | 16.518K | Mar 08 | View |
FAQ
Is Insider trading legal?
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
What are some examples of market manipulation?
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.